Evidence map›Paper›PMID 30903357›Full record

SynthesisHeart failure reviews2019

Valuing health-related quality of life in heart failure: a systematic review of methods to derive quality-adjusted life years (QALYs) in trial-based cost-utility analyses.

Jenny Rankin, Donna Rowen, Amanda Howe, John G F Cleland, Jennifer A Whitty

Abstract readSystematic Review
In one paragraph

Synthesis in Heart failure reviews, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Willingness to pay for a quality-adjusted life year: a systematic review with meta-regression.The European journal of health economics : HEPAC : health economics in prevention and care · 2022
    Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Development of a preference-based heart disease-specific health state classification system using MacNew heart disease-related quality of life instrument.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2022
    Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jenny RankinHealth Economics Group, Norwich Medical School, University of East Anglia, Norwich Research Park, Norwich, NR4 7JT, UK.
Donna RowenSchool of Health and Related Research, University of Sheffield, Sheffield, UK.
Amanda HoweHealth Economics Group, Norwich Medical School, University of East Anglia, Norwich Research Park, Norwich, NR4 7JT, UK.
John G F ClelandRobertson Centre for Biostatistics & Clinical Trials, University of Glasgow & National Heart & Lung Institute, Royal Brompton & Harefield Hospitals, Imperial College, London, UK.
Jennifer A WhittyHealth Economics Group, Norwich Medical School, University of East Anglia, Norwich Research Park, Norwich, NR4 7JT, UK. Jennifer.whitty@uea.ac.uk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The accurate measurement of health-related quality of life (HRQoL) and the value of improving it for patients are essential for deriving quality-adjusted life years (QALYs) to inform treatment choice and resource allocation. The objective of this review was to identify and describe the approaches used to measure and value change in HRQoL in trial-based economic evaluations of heart failure interventions which derive QALYs as an outcome. Three databases (PubMed, CINAHL, Cochrane) were systematically searched. Twenty studies reporting economic evaluations based on 18 individual trials were identified. Most studies (n = 17) utilised generic preference-based measures to describe HRQoL and derive QALYs, commonly the EQ-5D-3L. Of these, three studies (from the same trial) also used mapping from a condition-specific to a generic measure. The remaining three studies used patients' direct valuation of their own health or physician-reported outcomes to derive QALYs. Only 7 of the 20 studies reported significant incremental QALY gains. Most interventions were reported as being likely to be cost-effective at specified willingness to pay thresholds. The substantial variation in the approach applied to derive QALYs in the measurement of and value attributed to HRQoL in heart failure requires further investigation.

Indexed as

Quality-Adjusted Life YearsQuality of LifeCost-Benefit AnalysisHealth Care CostsHealth Services ResearchHealth Status IndicatorsHeart FailureHumansPsychometricsCost-effectivenessCost utility analysisEconomic evaluationHealth-related quality of lifeHeart failureQALY

Identifiers

PMID30903357
PMCPMC6560006

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.